Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A by Castaman G, Linari S

Get full text

Obstacles to Early Diagnosis and Treatment of Inherited von Willebrand Disease: Current Perspectives by Castaman G, Linari S

Get full text

Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence by Linari S, Castaman G

Get full text

A proteomic analysis of changes in prothrombin and plasma proteins associated with the G20210A mutation. by Gelfi, C, Viganò, A, Ripamonti, M, Wait, R, Begum, S, Biguzzi, E, Castaman, G, Faioni, E

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery. by Peyvandi, F, Mamaev, A, Wang, J-D, Stasyshyn, O, Timofeeva, M, Curry, N, Cid, AR, Yee, TT, Kavakli, K, Castaman, G, Sytkowski, A